Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory

References

Page 1

	Year	Citations
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study Lesley Wood, Matthias Egger, Lise Lotte Gluud, BMJ	2008	2.5K
The Cochrane Library Deborah H. Charbonneau Europe PMC (PubMed Central) DatabasesEvidence-based MedicineClinical GuidelinesUnited KingdomMedical History	2005	2K
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis Peter Jüni JAMA	1999	2K
Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials An‐Wen Chan, Asbjørn Hróbjartsson, Mette T. Haahr, JAMA	2004	1.8K
Effect of encouragement on walking test performance. Gordon Guyatt, Stewart Pugsley, Michael Sullivan, Thorax Functional Movement ScreeningPhysical ActivityKinesiologyPhysical FitnessExercise	1984	811
Epidemiology and reporting of randomised trials published in PubMed journals An‐Wen Chan, Douglas G. Altman The Lancet Retrospective Cohort StudyEpidemiological OutcomeRandomised TrialsEpidemiologic ResearchClinical Trials	2005	475
The impact of blinding on the results of a randomized, placebo‐controlled multiple sclerosis clinical trial John H. Noseworthy, George C. Ebers, Margaret K. Vandervoort, Neurology	1994	332
Physician Interpretations and Textbook Definitions of Blinding Terminology in Randomized Controlled Trials P.J. Devereaux JAMA	2001	258
The Landscape and Lexicon of Blinding in Randomized Trials Kenneth F. Schulz, Iain Chalmers, Douglas G. Altman Annals of Internal Medicine	2002	244
In the dark The reporting of blinding status in randomized controlled trials Víctor M. Montori, Mohit Bhandari, P.J. Devereaux, Journal of Clinical Epidemiology OphthalmologyHealth PolicyControlled TrialsClinical TrialsRandomized Controlled Trial	2002	176

Page 1